ChemicalBook > CAS DataBase List > Tofacitinib Impurity
Tofacitinib Impurity
- Product Name
- Tofacitinib Impurity
- CAS No.
- 2282653-53-4
- Chemical Name
- Tofacitinib Impurity
- Synonyms
- Tofacitinib Impurity ZJT1-F;(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-dimethyl-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N,N-dimethyl-;(E)-methyl 3-amino-2-cyano-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopent-2-enoate
- CBNumber
- CB26226035
- Molecular Formula
- C8H9ClN4
- Formula Weight
- 196.64
- MOL File
- 2282653-53-4.mol
More
Less
Tofacitinib Impurity Property
- Density
- 1.422±0.06 g/cm3(Predicted)
- pka
- 12.47±0.50(Predicted)
Tofacitinib Impurity Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Tofacitinib Impurity Suppliers
- Tel
- 021-16621358918; 18516310516
- Fax
- 13045646768
- zhenlipharma888@163.com
- Country
- China
- ProdList
- 2000
- Advantage
- 58
- Tel
- 25-57027686 17372956142
- Fax
- 025-57027686
- li_lan@syntitan.com
- Country
- China
- ProdList
- 10000
- Advantage
- 58
- Tel
- +8615255079626
- eric@witopchemical.com
- Country
- China
- ProdList
- 23541
- Advantage
- 58
- Tel
- 2710913286@.com
- 1513643261@qq.com
- Country
- China
- ProdList
- 14246
- Advantage
- 58
- Tel
- 0755-61348847 17820674378
- Fax
- 0755-21016893
- 2682116078@qq.com
- Country
- China
- ProdList
- 7843
- Advantage
- 58
- Tel
- 400-820-6829
- sales@mitachieve.com
- Country
- China
- ProdList
- 8860
- Advantage
- 58
- Tel
- 0755-0755-0755-83725350 13380397412
- Fax
- 0755-28094224
- 3001280422@qq.com
- Country
- China
- ProdList
- 10005
- Advantage
- 58
- Tel
- 0755-66853366; 13670046396
- ORDERS@QCSRM.COM
- Country
- China
- ProdList
- 24326
- Advantage
- 58
- Tel
- 14760821013 13564957716
- 1816280386@qq.com
- Country
- China
- ProdList
- 7522
- Advantage
- 58
- Tel
- 021-54580889 18321124657
- Fax
- 021-54580889
- 731997554@qq.com
- Country
- China
- ProdList
- 10608
- Advantage
- 58
2282653-53-4, Tofacitinib ImpurityRelated Search:
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
Tofacitinib Impurity 36
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
Tofacitinib Related Compound
Tofacitinib Impurity 45
Tofacitinib Impurity 2